Trends in Biotechnology mass spectrometry (LC-MS/MS) (see Glossary) methods. Despite its high specificity, matrix interference may lead to falsely low or high results; that is, the matrix and co-eluting compounds can interfere with the ionization process in MS (via ion suppression/enhancement) [5]. Furthermore, the throughput of LC-MS/MS is lower than that of the conventional immunoassay platforms. Recent studies are either addressing these issues [6,7] or exploiting or improving this method's inherent advantages [8,9]. Accordingly, there has been a significant effort to increase the throughput of chromatographic methods [10]. Pioneering multiplex approaches have been reported for antiretroviral agents (ARVs) [11], antifungals [12], antineoplastics [13], antibiotics [6,7,14], antidepressants [15], and immunosuppressive drugs [16] in the past decade. More recently, ultra-performance liquid chromatography (UPLC)-MS/MS has been used for simultaneous quantification of antibiotics [17] and ARVs from plasma [11] and breast milk samples [18]. Another focus is the extension of TDM studies toward unconventional samples and sampling. Several LC-MS/MS methods have been developed and applied for hair [11,18], dried blood spots [19], urine [20], sweat [21], saliva [22,23], and tissue biopsies [24].